Status:
COMPLETED
Sleep in Pediatric HSCT
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Rutgers University
NJ Dept of Health Commission on Cancer Research
Conditions:
Sleep
Stem Cell Transplant Complications
Eligibility:
All Genders
8-21 years
Phase:
NA
Brief Summary
Through an aggregated N=1 randomized controlled design (each patient will serve as their own control, with the 5-day intervention period determined by randomization), the current study will test the a...
Detailed Description
Context: Patients undergoing treatment for cancer face disease, treatment, and environmental obstacles to sufficient, sound sleep. Hospitalizations can further worsen sleep quality and quantity due to...
Eligibility Criteria
Inclusion
- Males or females age 8 to 21 years.
- Undergoing HSCT at The Children's Hospital of Philadelphia
- Parent/guardian permission (informed consent) and if appropriate, child assent.
Exclusion
- History of developmental delays given the relationship to sleep/wake patterns
- Sleep disorder diagnosis as documented in the medical record
- Cognitive delays that impact the ability to complete study measures
- Not proficient in English
Key Trial Info
Start Date :
November 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04106089
Start Date
November 18 2019
End Date
December 1 2022
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104